eFFECTOR Therapeutics to Collaborate with Pfizer and Merck KGaA, Darmstadt, Germany to Evaluate a No
top of page
Companies in the News
SAN DIEGO, June 20, 2017 /PRNewswire/ -- eFFECTOR Therapeutics announced today it has entered into a clinical collaboration and supply...
- Jun 7, 2017
BlackThorn Therapeutics Announces Innovative Clinical Collaboration Agreement with Mindstrong Health
BLACKTHORN’S BTRX-246040 NOCICEPTIN PROGRAM IS FIRST MOLECULE AND CLINICAL PROGRAM TO INCORPORATE MINDSTRONG HEALTH’S PATENTED TECHNOLOGY...
- Apr 24, 2017
Sienna Biopharmaceuticals Announces $40 Million Series B Financing
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Sienna Biopharmaceuticals, Inc., a privately held, clinical stage medical dermatology and...
- Jan 9, 2017
Indigo’s Preliminary Commercial Data Demonstrate Significant Yield Gains for Growers with Plant Micr
Indigo™ Cotton demonstrated an average yield improvement of 11% in the target environment of West Texas Farmers experienced productivity...
- Jan 6, 2017
Vir Biotechnology Launches To Cure, Treat, And Prevent Challenging Infectious Diseases Using Latest
-Former Biogen leader George Scangos will be CEO, with Vicki Sato as Chairman of the Board -Company to apply immune programming at...
- Dec 6, 2016
Sienna Biopharmaceuticals Acquires Creabilis plc
Acquisition Adds Phase IIb Product, Clinical Candidates and Novel Discovery Platform to Sienna's Growing Pipeline WESTLAKE VILLAGE,...
- Oct 20, 2016
BlackThorn Therapeutics Launches to Develop Novel, Targeted Treatments for Neurobehavioral Disorders
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--BlackThorn Therapeutics, a clinical stage biopharmaceutical company discovering and...
- Jul 21, 2016
Indigo Raises $100M in Series C Funding; Company Launches First Commercial Product for Water Efficie
BOSTON, MASS. — July 21, 2016 — Indigo, a company dedicated to harnessing nature to help farmers sustainably feed the planet, announced...
- Jul 12, 2016
Sienna Biopharmaceuticals Announces Second Closing of Series A Financing
STRONG INVESTOR DEMAND INCREASES TOTAL INVESTMENTS TO $46M Westlake Village, CA, July 12, 2016 – Sienna Biopharmaceuticals, Inc....
bottom of page